FIELD: pharmaceuticals.
SUBSTANCE: invention relates to an application of protein B2UM07 containing an amino acid sequence with SEQ ID NO: 2 for suppressing appetite in a subject with reduced hormone GLP-1 and for preventing or treating metabolic disorders associated with hormone GLP-1. Also proposed are pharmaceutical compositions and healthy nutrition products containing said protein B2UM07 as an active substance.
EFFECT: protein B2UM07 provides a high capacity for GLP-1 induction, a capacity for maintaining the glucose homeostasis in the body, and an impact on weight loss.
20 cl, 12 dwg, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AKKERMANSIA MUCINIPHILA STRAIN AND ITS APPLICATION | 2019 |
|
RU2792651C2 |
| PROTEINS WITH A DOUBLE FUNCTION AND A PHARMACEUTICAL COMPOSITION CONTAINING THEM | 2016 |
|
RU2741345C2 |
| FGF21 Fc FUNCTION PROTEIN, GLP-1 Fc FUNCTION PROTEIN AND COMBINED THERAPEUTIC AGENT INCLUDING THEM AND THEIR USE | 2020 |
|
RU2804335C2 |
| LYOPHILISED ANTIBACTERIAL PROTEIN COMPOSITIONS | 2017 |
|
RU2734308C2 |
| NEW MODIFIED IMMUNOGLOBULIN Fc-FRAGMENT FUNCTION PROTEIN AND ITS USE | 2020 |
|
RU2800919C2 |
| GIPR ANTIBODY AND ITS GLP-1 FUNCTION PROTEIN AS WELL AS PHARMACEUTICAL COMPOSITION BASED ON IT AND ITS USE | 2019 |
|
RU2800370C2 |
| BISPECIFIC PROTEIN | 2019 |
|
RU2784486C1 |
| MUCOADHESIVE MICROORGANISM | 2017 |
|
RU2762940C2 |
| MICROORGANISM PRODUCING PUTRESCINE OR ORNITHINE AND METHOD FOR PRODUCING PUTRESCINE OR ORNITHINE USING THIS MICROORGANISM | 2016 |
|
RU2759956C1 |
| GLP-2 PEPTIBODY FOR INTRODUCTION BEFORE, DURING OR AFTER SURGICAL INTERVENTION | 2018 |
|
RU2795594C2 |
